Farmers ‘anxiously’ await decision on new herbicide and herbicide-resistant GM crops

Faced with tougher and more resistant weeds, corn and soybean farmers are anxiously awaiting government decisions on a new version of a popular herbicide — and on genetically modified seeds to grow crops designed to resist it.

Critics say more study is needed on the effects of the herbicide and they are concerned it could endanger public health.

The Environmental Protection Agency is expected to rule this fall on Dow AgroSciences’ application to market Enlist, a new version of the 2,4-D herbicide that’s been around since the 1940s. It’s partly a game of catch-up for the agriculture industry, as many farmers are dealing with weeds that have become resistant to glyphosate, an herbicide commonly used on corn and soybeans now.

If approved, the 2,4-D would be used in combination with glyphosate.

An Agriculture Department decision on the company’s genetically modified seeds also is expected this fall. In the department’s final environmental review released last week, the USDA recommended approval. The agency said that if both the seeds and herbicide are approved, the use of 2,4-D could increase by an estimated 200 to 600 percent by the year 2020.

Read the full, original article: Decision could boost use of popular weed-killer

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
ChatGPT-Image-May-12-2026-11_27_01-AM-2
AI likely to improve health care, research shows—but not for blacks and ethnic minorities
ChatGPT-Image-May-7-2026-01_23_27-PM-2
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.